-+ 0.00%
-+ 0.00%
-+ 0.00%

Tevogen grants CEO Ryan Saadi 8 million restricted shares tied to $1 billion revenue target by 2031

PUBT·09/16/2026 21:13:40
Listen to the news
Tevogen grants CEO Ryan Saadi 8 million restricted shares tied to $1 billion revenue target by 2031
  • Tevogen granted restricted stock awards on Sept. 14, 2026 under its 2024 Omnibus Incentive Plan.
  • CEO Ryan Saadi received 8,000,000 restricted shares; CFO Kirti Desai received 750,000 restricted shares.
  • Vesting requires board certification of $1 billion aggregate revenue by Sept. 30, 2031.
  • Shares carry voting rights before vesting; transfers are barred until vesting.
  • Unvested awards are forfeited if the revenue target is missed or service ends before vesting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042952), on September 16, 2026, and is solely responsible for the information contained therein.